Synergy Asset Management, LLC Novartis Ag Transaction History

Synergy Asset Management, LLC

  • $646 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
SELL
$92.57 - $107.37 $615,590 - $714,010
-6,650 Reduced 25.04%
19,905 $2.12 Million
Q1 2024

Apr 18, 2024
SELL
$95.27 - $108.47 $407,183 - $463,600
-4,274 Reduced 13.86%
26,555 $2.57 Million
Q4 2023

Jan 19, 2024
SELL
$92.27 - $101.54 $309,381 - $340,463
-3,353 Reduced 9.81%
30,829 $3.11 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $780,385 - $866,060
8,238 Added 31.75%
34,182 $3.48 Million
Q2 2023

Aug 02, 2023
BUY
$92.52 - $104.91 $2.4 Million - $2.72 Million
25,944 New
25,944 $2.62 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $226B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Synergy Asset Management, LLC Portfolio

Follow Synergy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synergy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Synergy Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email